🔎 Trials Near Me

Acasă › Cancer pulmonar › West Virginia

Studii clinice pentru Cancer pulmonar în West Virginia

11 studii pentru Cancer pulmonar caută participanți în West Virginia.

Orașe în West Virginia

Text oficial al studiului (în engleză)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • United Hospital Center, Bridgeport
  • Edwards Comprehensive Cancer Center, Huntington
  • West Virginia University Healthcare, Morgantown
  • și încă 2
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 2 oct. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Edwards Comprehensive Cancer Center, Huntington
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Edwards Comprehensive Cancer Center, Huntington
În curs de recrutareFaza 3
Vârste de 70 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Vandalia Health/CAMC Institute for Academic Medicine, Charleston
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Edwards Comprehensive Cancer Center, Huntington
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 1 oct. 2026 · NCT06498635

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • West Virginia University Hospitals - Mary Babb Randolph Cancer Center, Morgantown
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06712316

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Edwards Comprehensive Cancer Center, Huntington
  • West Virginia University Healthcare, Morgantown
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 17 aug. 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Edwards Comprehensive Cancer Center, Huntington
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 3 iun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Edwards Comprehensive Cancer Center, Huntington
  • West Virginia University Healthcare, Morgantown
În curs de recrutareFaza 2
18 Minutes · Toate sexele · Actualizat 5 mai 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • United Hospital Center, Bridgeport
  • Edwards Comprehensive Cancer Center, Huntington
  • WVUH-Berkely Medical Center, Martinsburg
  • și încă 3
În curs de recrutareFaza 2/3
Vârste de 18 ani și peste · Toate sexele · Actualizat 5 mai 2026 · NCT06616584

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Morgantown
În curs de recrutareStudiu observațional
Toate vârstele · Toate sexele · Actualizat 28 oct. 2025 · NCT03452774

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.